GERN
Asset Logo

Geron Corporation

๐Ÿ‡บ๐Ÿ‡ธ NYSE/NASDAQ

๐Ÿ“ˆ HIGH PRICE GROWTH

Compare
Add to watchlist
๐Ÿ‘‘ Overview

๐Ÿ“ˆ Performance

๐Ÿ’ต Cost

๐Ÿƒ Esg

๐Ÿค“ Advanced

๐Ÿ‘จโ€๐Ÿ‘ฉโ€๐Ÿ‘งโ€๐Ÿ‘ฆ Community

๐Ÿ“ˆ

+ 40.00%
Annual Growth

5 years average annual growth

๐ŸŒ

1
Pearlers Invested

Since January 2020

๐Ÿ‘‘ Overview

Key information
๐Ÿ”Ž Fund Overview

Geron Corporation is a late-stage clinical biopharmaceutical company developing investigational first-in-class telomerase inhibitor, imetelstat, to treat hematologic malignancies. The Company is engaged in the development of therapeutic products for oncology. Its lead indication for imetelstat is in Low or Intermediate-1 risk myelodysplastic syndromes. It is developing imetelstat for the treatment of several myeloid hematologic malignancies, including a Phase 3 clinical trial, named IMpactMF, in relapsed/refractory myelofibrosis (MF) with overall survival as the primary endpoint, that is enrolling patients. It is also conducting a Phase 1 combination therapy clinical trial, named IMproveMF, in first-line Intermediate-1, Intermediate-2 or High-Risk myelofibrosis, or frontline MF, that is enrolling patients and imetelstat is being studied in an investigator-led Phase 2 clinical trial, named IMpress, in Intermediate-2 or High-Risk myelodysplastic syndromes and acute myeloid leukemia.

๐Ÿ“ˆ Performance

Price History*

+8.94%

1M

1Y

10Y

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
๐Ÿ—“๏ธ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out โ†’
๐Ÿ’ต Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out โ†’
โฑ๏ธ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out โ†’

๐Ÿ’ต Costs

๐Ÿ’ต

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

๐Ÿ’ผ

N/A
Management Fee

Included in unit price, not charged by Pearler

๐Ÿ’ธ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐Ÿ’ธ Net fee calculator

๐Ÿค“ Advanced information

Technical Info

๐Ÿ’ฐ Price*

$4.02

*Price may be up to 24 hours old

๐Ÿ‘ฉโ€๐Ÿ‘ฉโ€๐Ÿ‘ฆ Community Insights

How our community is investing

๐ŸŒ Pearlers invested in GERN

1

๐Ÿ“Š Total Capital Earnings

N/A

๐Ÿ”ƒ Average investment frequency

25 weeks

๐Ÿ’ต Average investment amount

$208

โฐ Last time a customer invested in GERN

41 days
GERN investor breakdown
๐Ÿ’ต Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

100%

Less than 50k

๐Ÿ‘ถ Age of investors

18 - 25

26 - 34

35 - 90

100%
๐Ÿ™‹ Legal gender of investors

Female

100%

Male

Pearlers who invest in GERN also invest in...

NVIDIA Corporation

NVDA

๐Ÿ™Œ Performance (5Yr p.a)

538.48%

๐Ÿ“Š Share price

$146.67 USD

๐Ÿ“ˆ HIGH PRICE GROWTH

Find Out More

๐Ÿ™Œ Performance (5Yr p.a)

49.61%

๐Ÿ“Š Share price

$137.49 USD

๐Ÿ“ˆ HIGH PRICE GROWTH

๐Ÿ™Œ Performance (5Yr p.a)

894.82%

๐Ÿ“Š Share price

$198.38 USD

๐Ÿ™Œ Performance (5Yr p.a)

49.77%

๐Ÿ“Š Share price

$228.52 USD

๐Ÿ“ˆ HIGH PRICE GROWTH

๐Ÿ™Œ Performance (5Yr p.a)

28.21%

๐Ÿ“Š Share price

$45.70 USD

๐Ÿ“ˆ HIGH PRICE GROWTH

Want more shares? Try these...

๐Ÿ™Œ Performance (5Yr p.a)

-0.73%

๐Ÿ“Š Share price

$16.63 USD

๐Ÿ™Œ Performance (5Yr p.a)

-0.40%

๐Ÿ“Š Share price

$13.62 USD
Compare
Add to watchlist